Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Spike In Drug Recalls Expected As US FDA Resumes Inspections, Targeting COVID-19-Related Problems

Oct 01 2020

White lightbox with word fda recall on wood background

Related Content

The Quality Lowdown: COVID-19's Pressures On Drug Quality

Aug 13 2020

What The FDA’s Inspections Q&A Guidance Really Means: It’s Time To Offer Virtual Inspections

Aug 25 2020

US FDA Announces Plans To Resume Domestic Inspections

Jul 10 2020

US FDA Suspends All Domestic GMP Surveillance Inspections

Mar 18 2020

US FDA Clarifies Testing In Sanitizer Production Temporary Guidances To Tighten Compliance

Aug 10 2020

US FDA Adds Hand Sanitizer Import Alert Category After COVID-19 Production Surge Turned Deadly

Sep 18 2020

No Hiding Bogus Coronavirus Claims From US Regulators In Social Media Or With Vague Terms

Sep 23 2020

Complete Response Letters In Lieu Of Inspections: What To Expect During COVID-19

Sep 07 2020

Perrigo's Recall Flushes Ranitidine OTC Private Label And Store Brand Products From US Market

May 04 2020

Related Companies

Stericycle, Inc.

Apotex Inc.

Amneal Pharmaceuticals, Inc.

Actavis Group

Lupin Limited

Additional Topics

International United States Recalls FDA OTC Drugs Advertising, Marketing & Sales Commercial Compliance Dietary Supplements Distribution Enforcement Manufacturing Policy Regulation Safety Consumer

More from Recalls

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window